Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Create nofollow/noindex links
。搜狗输入法下载对此有专业解读
+__init__(db_path: str)，更多细节参见爱思助手下载最新版本
* 序列: 1, 5, 19, 41, 109, ...
Save to wishlistSave to wishlist